ArticlePflugers Archiv : European journal of physiology1994
Modulation of the inhibitory action of ATP on acetylcholine-activated current by protein phosphorylation in rat sympathetic neurons.
Article in Pflugers Archiv : European journal of physiology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 8 citations in OpenAlex.
- Functional interactions between nicotinic and P2X channels in short-term cultures of guinea-pig submucosal neurons.The Journal of physiology · 1998Article
- Vasoactive intestinal polypeptide modulation of nicotinic ACh receptor channels in rat intracardiac neurones.The Journal of physiology · 1996Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Modulation by protein phosphorylation of the relation between acetylcholine (ACh)-activated current (IACh) and adenosine triphosphate-(ATP)-activated current (IATP) was investigated with the whole-cell voltage-clamp technique in rat sympathetic neurons. During simultaneous activation by 100 microM ATP of an inward current, the current evoked by 100 microM ACh was reduced to 60-70% of that in the absence of ATP. Effects of compounds that are known to modulate protein phosphorylation were tested by including them in the intracellular solution. The reduction of IACh by ATP was not observed when K252a (1 microM), a non-selective protein kinase inhibitor, adenosine 5'-O-(3-thiotriphosphate) (ATP[gamma S], 1 mM) or alpha, beta-methylene ATP (1 mM) were included in the intracellular solution. Activators of protein kinases, adenosine 3',5'-cyclic monophosphate (cAMP, 100 microM), guanosine 3',5'-cyclic monophosphate (cGMP, 100 microM), phorbol 12-myristate 13-acetate (PMA, 1 microM), also abolished the reduction by ATP of IACh. The effects of okadaic acid, a protein phosphatase inhibitor, were paradoxical: okadaic acid (2 microM) itself abolished the reduction by ATP of IACh but it "antagonized" the abolishment by cAMP or cGMP of the reduction of IACh. Okadaic acid did not affect the disappearance of the reduction of IACh by ATP in the presence of intracellular PMA. The results suggest that the interaction between IACh and IATP is regulated by protein phosphorylation/dephosphorylation. Possible mechanisms underlying the effects of these modulators of protein phosphorylation are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.